Suprotik (Protik) serves as Managing Partner of Helena Special Investments.
He continues to serve as a Senior Advisor to Wesray Social Investments, the family office of Helena Member and investor Ray Chambers, overseeing their investments in healthcare, climate and sustainable investing.
Protik was previously Partner and Founder at Blue like an Orange Sustainable Capital, a mezzanine credit/subordinated debt-focused impact fund – – where he originated and led transactions, was Head of Sustainable Impact, served on the Investment Committee, and chaired the Sustainability and ESG Committee. He exited Blue Orange coinciding with the sale of a minority interest to AXA. Prior to his work in private finance, Protik was Chief Executive Officer for the Office of the UN Secretary General’s Special Envoy for Health Financing.
During his tenure as CEO, and prior to that as its Managing Director, Protik led the group’s efforts over a decade to mobilize and deploy over $3.5 billion of resources to end deaths from malaria in Africa, and to improve child and maternal health in sub-Saharan Africa and South Asia.
Through the distribution of over 2 billion mosquito nets and hundreds of millions of medications, this unprecedented public-private partnership saved the lives of over 7 million children from malaria in one of the largest public health efforts in history.
Protik also oversaw the formation of the End Malaria Council, co-chaired by Ray Chambers, Bill Gates, and President Ellen Johnson Sirleaf, and which laid out a roadmap to eradicate malaria worldwide. He previously held positions at the World Bank and World Health Organization, working in sub-Saharan Africa and South Asia.
He is a board member of several non-profits, including Big Win Philanthropy; the social justice non-profit founded by the late Dr. Paul Farmer, Partners in Health; as well as the Canadian multinational charity, Nutrition International.
Protik holds undergraduate and graduate degrees from The Johns Hopkins University and the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland. He currently serves on the Advisory Board of the Johns Hopkins Bloomberg School of Public Health.